HomeTMDX • NASDAQ
add
TransMedics Group Inc
Previous close
$128.50
Day range
$122.63 - $128.75
Year range
$55.00 - $177.37
Market cap
4.29B USD
Avg Volume
1.12M
P/E ratio
65.02
Dividend yield
-
Primary exchange
NASDAQ
Top news
Q2 earnings report for Transmedics Group Inc
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 157.37M | 37.68% |
Operating expense | 60.02M | 5.76% |
Net income | 34.91M | 186.26% |
Net profit margin | 22.18 | 107.87% |
Earnings per share | 0.92 | 162.86% |
EBITDA | 43.30M | 153.10% |
Effective tax rate | 3.52% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 400.58M | 10.43% |
Total assets | 890.52M | 17.39% |
Total liabilities | 572.42M | 0.66% |
Total equity | 318.10M | — |
Shares outstanding | 34.09M | — |
Price to book | 13.76 | — |
Return on assets | 10.58% | — |
Return on capital | 11.27% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 34.91M | 186.26% |
Cash from operations | 91.61M | 256.21% |
Cash from investing | -9.08M | 61.81% |
Cash from financing | 7.09M | -33.38% |
Net change in cash | 90.43M | 621.49% |
Free cash flow | 66.72M | 745.25% |
About
Founded
1998
Headquarters
Website
Employees
728
